Adverse effect of thrombolytic drugs, initial encounter

This code signifies an undesirable or harmful reaction experienced by a patient due to the therapeutic use of a thrombolytic medication. These drugs are administered to dissolve blood clots, and an adverse effect indicates a negative consequence arising from their intended pharmacological action, rather than an accidental overdose or poisoning.

Apply this code when a patient presents with symptoms or conditions directly attributable to the therapeutic administration of a thrombolytic agent, such as bleeding complications (e.g., intracranial hemorrhage, gastrointestinal bleeding), allergic reactions, or reperfusion injury, during their initial treatment or evaluation for the adverse effect.

• Always assign an additional code to specify the exact nature of the adverse effect (e.g., R58 for hemorrhage, T78.40XA for unspecified allergy).
• Ensure documentation clearly links the adverse event to the thrombolytic drug and confirms it occurred during the initial phase of treatment or assessment.
• Distinguish adverse effects from poisoning (T45.62-) or underdosing (T45.6X6-), which have different code assignments.